Green synthesis provides an environmentally friendly approach for producing gold nanoparticles (AuNPs) using biological resources. Despite the reported medicinal potential of Nonea lutea , its use for AuNPs synthesis remains largely unexplored. Therefore, this study aimed to synthesize N. lutea -mediated AuNPs (N@AuNPs) and evaluate their physicochemical, biological, and catalytic properties. N@AuNPs were synthesized using a methanolic extract of N. lutea aerial parts and characterized by UV–Vis, FE-SEM, XRD, FT-IR, EDX, TEM, and zeta potential analyses. Their antioxidant, catalytic, antibacterial, antileishmanial, and α -glucosidase inhibitory activities were evaluated. Caffeic acid, epicatechin, and p -coumaric acid were identified in the methanolic extract by HPLC based on comparing the retention times with the corresponding authentic standards. The formation of N@AuNPs was indicated by a surface plasmon resonance peak at 540 nm. TEM revealed predominantly spherical nanoparticles with an average size of 6.614 ± 2.686 nm, while the zeta potential was − 57.8 mV. XRD analysis further demonstrated the presence of crystalline metallic gold, with a crystallite size of 8.13 nm. N@AuNPs showed DPPH scavenging activity with an IC₅₀ of 108.47 ± 4.26 μg/mL and catalytic reduction efficiencies of 89.05%, 77.83%, and 96.48% for methyl orange, 4-nitrophenol, and rhodamine B, respectively. Antibacterial activity was strain-dependent, with MICs of 12.5–100 μg/mL. N@AuNPs also exhibited antileishmanial and α -glucosidase inhibitory activities. Overall, N. lutea -mediated synthesis yielded crystalline, predominantly spherical AuNPs with antioxidant, catalytic, antibacterial, antileishmanial, and α -glucosidase inhibitory activities.
No takes yet. Share an insight, caveat, or question.
Kalan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: